Cipla Limited (LUX:CIPLA)

Market Cap	10.33B -19.1%
Revenue (ttm)	2.56B +1.6%
Net Income	358.81M -26.4%
EPS	0.44 -26.4%
Shares Out	n/a
PE Ratio	28.78
Forward PE	27.57
Dividend	0.12 (0.82%)
Ex-Dividend Date	Jun 26, 2025

Volume	n/a
Open	n/a
Previous Close	14.60
Day's Range	n/a
52-Week Range	12.80 - 18.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2026

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 30,313
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: CIPLA

Financial Performance

In fiscal year 2026, Cipla's revenue was 277.12 billion, an increase of 1.63% compared to the previous year's 272.67 billion. Earnings were 38.79 billion, a decrease of -26.43%.

Financial numbers in INR